1.Optimization of the Preparation Technology of Buqi Tongmai Capsule by Orthogonal Experiment
China Pharmacy 2001;0(07):-
OBJECTIVE: To optimize the preparation technology of Buqi tongmai capsule.METHODS: Orthogonal experiment of exeracting Radix Astragali was conducted with crude drugs soaking time,extracting times,amount of water added and decocting duration as factors and the content of astragaloside as index.Orthogonal experiment of exeracting Salvia miltiorrhiza,Ligusticum chuanxiong,Fructus Aurantii Immaturus,Carthamus tinctorius was conducted with crude drugs soaking time,amount of water added and decocting duration as factors and the content of tanshinol as index.RESULTS:Water was adopted for extraction and the concentration of alcohol for precipitate was 70 percent.The optimal technology of exeracting Radix Astragali was to soak the crude drugs for 30 min,decoct for 90 min in 10 times of water for 2 times.The optimal technology of exeracting S.miltiorrhiza,L.chuanxiong,Fructus Aurantii Immaturus,C.tinctorius was to decoct the crude drugs for 90 min,8 times of water for 2 times.CONCLUSION:The preparation processes is feasible,stable and meet the demands in the clinic.
2.Clinical Observation on 150 Patients with Diabetes Type Ⅱ Treated by Qiyao Xiaoke Capsule Combined with Metformin Hydrochloride Tablets:A Multi-centered Random-Controlled Study
Journal of Traditional Chinese Medicine 1993;0(06):-
Objective To observe the therapeutic effect of Qiyao Xiaoke Capsule(Capsule for Diabetes) on the diabetes type Ⅱ.Methods Totally 240 diabetes type Ⅱ patients were randomized into a treatment group(n=150),and a control group(n=90);and other 30 diabetes patients who didn't regularly take hypoglycemic drugs were set as opening group.The treatment group was administered Qiyao Xiaoke Capsule plus Metformin Hydrochloride Tablets,while the control group was prescribed Xiaokeling Capsule in addition to Metformin Hydrochloride Tablets,and the opening group was given Qiyao Xiaoke Capsule only,with a leading period of two weeks.The patients were treated for 4 weeks.Before treatment and at the end of the 4 weeks' treatment,the fasting blood glucose(FBG),2 hours postprandial blood glucose(2hPG),and glycosylated hemoglobin(HbA1c) of all groups were determined,and scores of TCM syndromes and symptoms were observed to evaluate the therapeutic effect.Results The total effective rate of the treatment group was 74.67%,of the control group 72.22%,and in the opening group 70.00%.Except for the 2hPG of the opening group,the FBG,2hPG and HbA1c of 3 groups were decreased(P
3.Expression and Clinical Significance of Serum LCN-2 and MMP-9 in Patients with Breast Cancer
Journal of Modern Laboratory Medicine 2015;(1):72-74
Objective To evaluate the expression and its clinical significance of serum LCN-2 and MMP-9 in human breast cancer.Methods 96 patients with breast cancer,42 patients with benign breast diseases and 27 healthy controls were recrui-ted in this study.The LCN-2 and MMP-9 levels were measured by ELISA in the serum of 96 patients with breast cancer,42 patients with benign breast disease,and 27 health controls.Results The level of serum LCN-2 in the breast cancer group (89.76±28.38 ng/ml)was significantly higher than those in benign breast diseases (56.44±21.15 ng/ml)and healthy controls (44.32±16.84 ng/ml)(P<0.05).The level of serum MMP-9 in the breast cancer group (96.34±23.26 ng/ml) was significantly higher than those in benign breast diseases (28.16±11.57 ng/ml)and healthy controls (23.54±13.61 ng/ml)(P<0.05).No obvious difference in the levels of serum LCN-2 and MMP-9 was observed between benign breast disease and healthy controls (P>0.05).Correlation analysis showed that a positive correlation was found between the levels of serum LCN-2 and MMP-9 in breast cancer patients (r=0.513 5,P<0.05).The levels of serum LCN-2 and MMP-9 were significantly associated with tumor size,lymph node metastasis,the expression of ER and PR,TNM stage,but were not asso-ciated with tumor differentiation (P>0.05).The correlation analysis showed that the LCN-2 level was positive correlated with the MMP-9 level (P<0.05).Conclusion LCN-2 and MMP-9 could play a role in the tumorigenesis and development of breast cancer.Measuring of serum LCN-2 and MMP-9 may be a useful tool for diagnosis,effect monitoring and prognosis in breast cancer.
5.Relationship between the management of Graves' disease and the course of Graves' ophthaimopathy:a systematic review
Chinese Journal of Nuclear Medicine 2008;28(4):276-279
Objective To perform literature search and review on the controversial relationship between therapies of hyperthyroidism due to Graves'disease(GD)and the course of Graves'ophthalmopathy(CA)).Methods We searched the database of MEDLINE(1966-2006.3),EMBASE(1984-2005),Cochrane Library(2006 No.1),CBMdisc(1978.1-2006.4)and CNKI(1994-2006).The methodological quality of the studies selected for review was assessed according to the quality assessment criteria suggested by the Cochrane systematic review guideline.Meta-analysis was performed by RevMan 4.2 software.Results Eight studies were included in the systematic review.Meta-analysis showed that there was statistically significant difference between 131I and other forms of therapy[surgery or antithyroid drugs(ATD)](test value:2.31,5.97,3.70,5.55;all P<0.05)in aggravation of exophthalmos and symptom improvement in patients without receiving thyroxine during the early stage to prevent hypothyroidism.However,there was no statisti cally significant differenee in the above relationship between surgery and ATD therapy in those patients already receiving thyroxine supplement(test value:0.27,0.99;all P>0.05).There were not yet any studies on the impact between early prevention of hypothyroidism after 131I therapy and GO.Conclusions Based on meta-analysis on literature data,if early measures are not performed to prevent hypothyroidism after 131I therapy,it may induce or aggravate GO more frequently than ATD or surgical treatment.Symptomatic relief of GO after 131I therapy is also less effective than the other 2 forms of therapy.Therefore.131I therapy should be delivered carefully in those patients with GO.
6. Pharmacokinetic study of cefazedone sodium given by intravenous drip infusion in healthy volunteers
Chinese Pharmaceutical Journal 2012;47(4):291-295
OBJECTIVE: To investigate the pharmacokinetics of cefazedone sodium in Chinese healthy volunteers after a single or multiple dose of intravenous drip infusion. METHODS: Thirty healthy volunteers, half male and half female, were randomly assigned to three groups of single dose and one group of multiple dose. The plasma drug concentrations after intravenous drip of single dose of 0.5, 1.0, 2.0 g and multiple dose of 1.0 g cefazedone sodium were determined by HPLC-MS/MS. RESULTS: The pharmacokinetic parameters of cefazedone sodium after single dose of 0.5, 1.0, 2.0 g were obtained as follows: t1/2z were (1.85 ± 0.53), (1.81 ± 0.29), (2.07 ± 0.32) h, respectively; AUC0-t were (145.30 ± 68.67), (244.26 ± 38.284), (513.10 ± 127.27) mg · h · L-1; AUC0-∞ were (147.89 ± 70.45), (246.60 ± 40.61), (521.02 ± 134.33) mg · h · L-1; tmax were (0.30 ± 0.06), (0.33 ± 0.00), (0.35 ± 0.05) h; ρmax were(87.18 ± 36.37), (151.13 ± 19.02), (271.94 ± 38.86) mg · L-1; Vz were (9.97 ± 2.91), (10.67 ± 1.27), (11.75 ± 1.78) L, CLz were (3.88 ± 1.239), (4.14 ± 0.57), (4.03 ± 0.86) L · h-1, respectively. The multi-dose pharmacokinetic parameters of cefazedone sodium were obtained as follows: AUCss was (208.93 ± 37.37) mg · h · L-1; AUC0-t was (208.93 ± 37.37) mg · h · L-1; AUC0-∞ was (210.64 ± 38.55) mg · h · L-1; tmax was (0.33 ± 0.00) h; ρmax was(130.20 ± 22. 83)mg · L-1; ρss was (17.41 ± 3.11) mg · L-1; ρmin was (0.89 ± 0.60) mg · L-1; DF was (7.45 ± 0.70); t1/2z was(1.77 ± 0.25) h; Vz was (12.40 ± 2.57) L; CLz was (4.90 ± 0.95) L · h-1. CONCLUSION: Cefazedone sodium displays linear pharmacokinetics in the dose range of 0.5 to 2 g after single intravenous drip injection. No significant differences between genders are observed. The differences of the main pharmacokinetic parameters of tmax, t1/2z, Vz and CLz between each group are not significant (P > 0.05). There is no significant accumulation of cefazedone sodium in healthy volunteers after multiple intravenous drip injection. Copyright 2012 by the Chinese Pharmaceutical Association.
8.The effect of the′cocktail′wet compress on the prevention of arm swelling after trans radial percutaneous coronary procedures
Ping TANG ; Qiong HUANG ; Hongyan REN
Chongqing Medicine 2015;(30):4199-4200
Objective To test the effect and safety of′cocktail′wet compression on alleviate the swelling arm after the inter‐vention through the radial artery .Methods Patients whose arm were swollen after the intervention through radial artery were di‐vided into two groups (experiment group ,47 patients vs .control group ,46 patients) .The experiment group adopt the′cocktail′wet compress plus traditional therapy (including elevate and immobile the swelling arm);the control group only use the traditional ther‐apy .The levels of pain ,swelling index and the number of the blister were compared between two groups .Results None of the limbs necrosis was observed in two groups .The level of pain(2 .62 ± 0 .86 vs .5 .46 ± 1 .02) ,swelling index (3 .3% ± 2% vs .5 .8% ± 3% ) of the arm ,and the number of blister (0 vs .4) in experiment group were lower than in the control group (P<0 .05) .Conclusion The bundle of therapy strategy which named'cocktail'wet compress can lessen the swelling of the arm induced by intervention through radial artery ;it is both safe and effective thus deserves widely application .
9.Serum levels and clinical significance of IL in patients with delayed encephalopathy after acute carbon monoxide poisoning.
Long ZHEN ; Ren-jun GU ; Ping ZHANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2008;26(9):561-562
Adult
;
Aged
;
Aged, 80 and over
;
Carbon Monoxide Poisoning
;
complications
;
Female
;
Humans
;
Interleukins
;
blood
;
Male
;
Middle Aged
;
Neurotoxicity Syndromes
;
blood
;
etiology
10.One case of acute intermittent porphyria.
Ping ZHOU ; Zhi-min REN ; Qiang GAO
Chinese Journal of Pediatrics 2004;42(7):531-531